FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fulgent Genetics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$20.10+0.29 (+1.46%)
Close on Oct 19, 2026
- Market cap
- $562.90M
- P/E (TTM)
- –
- Dividend yield
- –
Fulgent Genetics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Market Cap | $553.06M | $1.14B |
| Enterprise Value | $291.87M | $1.35B |
| PS Ratio | 1.71 | 1.63 |
| PB Ratio | 0.55 | 3.03 |
| P/TBV Ratio | 0.69 | 4.99 |
Enterprise value
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| EV / Sales | 0.90 | 1.78 |
Income (trailing twelve months)
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Revenue | $323.93M | $561.90M |
| Gross Profit | $115.26M | $173.32M |
| Operating Income | -$122.28M | -$1.81M |
| Pretax Income | -$92.45M | -$572.42K |
| Net Income | -$84.38M | -$1.16M |
| EBITDA | -$96.46M | -$20.72K |
| EPS (Diluted) | -$2.82 | -$0.02 |
Margins
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Gross Margin | 35.6% | 33.1% |
| Operating Margin | -37.7% | -4.45% |
| Pretax Margin | -28.5% | 1.54% |
| Profit Margin | -26.0% | -2.91% |
| EBITDA Margin | -29.8% | 2.41% |
| FCF Margin | -32.0% | 3.13% |
Returns
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -7.97% | 1.84% |
| Return on Assets (ROA) | -7.37% | -3.06% |
| Return on Invested Capital (ROIC) | -10.9% | 2.11% |
| Return on Capital Employed (ROCE) | -12.0% | -0.57% |
Growth
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.83% | 6.92% |
| Revenue Growth (3Y CAGR) | -19.5% | 10.9% |
| Revenue Growth (5Y CAGR) | -5.21% | 13.2% |
Balance sheet
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $257.03M | $48.71M |
| Total Debt | $1.48M | $140.00M |
| Net Cash (Debt) | $255.56M | $205.49K |
| Net Cash Per Share | $9.29 | $0.01 |
| Equity (Book Value) | $1.00B | $235.16M |
| Book Value Per Share | $36.40 | $3.48 |
| Tangible Book Value | $798.50M | $703.69K |
| Working Capital | $383.01M | $30.48M |
Financial position
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Current Ratio | 6.34 | 1.40 |
| Quick Ratio | 4.49 | 1.02 |
| Debt / Equity | 0.00 | 0.66 |
| Interest Coverage | -1019.02 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Operating Cash Flow | -$83.70M | $3.10M |
| Capital Expenditures | -$20.09M | -$18.62M |
| Free Cash Flow | -$103.79M | $23.73M |
| FCF Per Share | -$3.77 | $0.37 |
Efficiency
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Asset Turnover | 0.28 | 0.87 |
| Inventory Turnover | 263.14 | 11.67 |
| Revenue Per Employee | $249.18K | $228.48K |
| Profits Per Employee | -$64.91K | -$8.65K |
| Employee Count | 1,300 | 913 |
Dividends and yields
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Earnings Yield | -15.3% | -1.25% |
| FCF Yield | -18.8% | 1.74% |
| Buyback Yield | 11.6% | 0.32% |
| Shareholder Yield | 11.6% | 0.65% |
Shares
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Shares Outstanding | 27,515,300 | 58,282,400 |
| Shares Change (YoY) | -1.49% | 2.68% |
| Shares Change (QoQ) | -4.63% | 0.32% |
| Float | 16,627,900 | 33,780,100 |
| Shares Held by Insiders | 39.6% | 16.4% |
| Shares Held by Institutions | 57.0% | 85.9% |
Taxes
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Income Tax | -$6.98M | $697.00K |
Scores
| Measure | Fulgent Genetics | Industry median |
|---|---|---|
| Altman Z-Score | 4.52 | 1.96 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -2.34 | -2.71 |
Calculated by StockData from Fulgent Genetics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.